GvHD Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the CMWP of the EBMT. Group Chronic Malignancies Working Party (CMWP) Principal investigator Thomas Luft
Survey Non-Tuberculous Mycobacterial infections post-hematopoietic stem cell transplantation Group Infectious Diseases Working Party (IDWP) Principal investigator Maria Stamouli
Daratumumab for PRCA after alloSCT Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Nico Gagelmann
Outcomes of PT-CY in elderly AML/MDS Diseases Group Transplant Complications Working Party (TCWP) Type of Stem Cell Treatment Principal investigator Maria Queralt Salas
Immune Checkpoint Inhibitors for solid tumors after allogeneic stem cell transplanation Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Jan Brijs
Pre-transplantation diabetes and obesity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation Group Transplant Complications Working Party (TCWP) Principal investigator Lars Klingen Gjaerde
Chronic GVHD over time - a multicenter retrospective study Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Drazen Pulanic
Steroid-free first line treatment of moderate and severe chronic GVHD - restrospective study Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Ivan Moiseev
Stratification of TCE group 3 permissive HLA-DPB1 mismatches in allogeneic hematopoietic cell transplantation Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of Stem Cell Treatment Principal investigator Esteban Arrieta-Bolaños
Survey on the current use of fecal microbiota transplantation (FMT) in patients with hematologic malignancies Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of Stem Cell Treatment Principal investigator F. Malard
Effects of donor clonal hematopoiesis in unrelated HSCT Diseases Group Transplant Complications Working Party (TCWP) Principal investigator F. Damm & J. Schetelig
Machine learning approach to estimate toxicity-related mortality following allogeneic HSCT Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Alberto Mussetti